Hot melt coating technology:: influence of Compritol® 888 Ato and granule size on chloroquine release

被引:0
|
作者
Faham, A
Prinderre, P
Piccerelle, P
Farah, N
Joachim, J
机构
[1] Fac Pharm Marseille, Lab Pharm Galen & Ind, F-13385 Marseille, France
[2] Gattefosse SA, St Priest, France
来源
PHARMAZIE | 2000年 / 55卷 / 06期
关键词
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The tangential splay technique was used to coat chloroquine granules with Compritol(R) 888 Ato in a fluidized bed (Glatt GPCG-1,1). After validation of the assay method for chloroquine, dissolution tests were carried out on four size fractions obtained from the same batch of granules. The dissolution profiles obtained showed differences in the rate of release between one fraction and another, despite the fact that each of these fractions had been coated with the same quantity of wax. This suggests that the rate of release of the chloroquine may be adjusted hv controlling the size of the granules. Furthermore these dissolution profiles were characterized by a rapid release phase followed by a slow release phase. Examination of the surfaces of the granules from the various size fractions under a scanning electron microscope revealed that Compritol(R) did not form a continuous film but existed rather as a lipid environment around the granule. This lipid environment was made up of solidified droplets: of the wax which had became piled up on the surface of the granule. Compression of the granules produced tablets which remained intact until chloroquine dissolution was complete. This undicated that the active substance diffused across the Compritol matrix generated during compression. Determination of the dissolution kinetics using the Higuchi model demonstrated the diffusion release mechanism.
引用
收藏
页码:444 / 448
页数:5
相关论文
共 50 条
  • [1] Hot-melt coating technology. I. Influence of compritol 888 Ato and granule size on theophylline release
    Faham, A
    Prinderre, P
    Farah, N
    Eichler, KD
    Kalantzis, G
    Joachim, J
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2000, 26 (02) : 167 - 176
  • [2] Compritol® 888 ATO:: an innovative hot-melt coating agent for prolonged-release drug formulations
    Barthelemy, P
    Laforêt, JP
    Farah, N
    Joachim, J
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1999, 47 (01) : 87 - 90
  • [3] Comparative study of the lubricant performance of Compritol® 888 ATO either used by blending or by hot melt coating
    Jannin, V
    Bérard, V
    N'Diaye, A
    Andrès, C
    Pourcelot, Y
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 262 (1-2) : 39 - 45
  • [4] Diluent Effects on Drug Release from Sustained-Release Compritol® 888 ATO Tablets
    Treanor, G.
    Roberts, M.
    Mostafa, S.
    Miolane, C.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2010, 62 (10) : 1419 - 1420
  • [5] Preparation and characterization of Compritol 888 ATO matrix tablets for the sustained release of diclofenac sodium
    Roberts, Matthew
    Pulcini, Lia
    Mostafa, Shabbir
    Cuppok-Rosiaux, Yvonne
    Marchaud, Delphine
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2015, 20 (04) : 507 - 512
  • [6] Development and evaluation of sustained-release Compritol® 888 ATO matrix mini-tablets
    Roberts, Matthew
    Vellucci, Daniele
    Mostafa, Shabbir
    Miolane, Cedric
    Marchaud, Delphine
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2012, 38 (09) : 1068 - 1076
  • [7] Influence of Formulation Factors and Compression Force on Release Profile of Sustained Release Metoprolol Tablets using Compritol® 888ATO as Lipid Excipient
    Patere, Shilpa N.
    Kapadia, Chhanda J.
    Nagarsenker, Mangal S.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 77 (05) : 620 - 625
  • [8] In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets
    Li, Feng-Qian
    Hu, Jin-Hong
    Deng, Jia-Xin
    Su, Hua
    Xu, Shu
    Liu, Ji-Yong
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 324 (02) : 152 - 157
  • [9] Optimizing a wet granulation process to obtain high-dose sustained-release tablets with Compritol 888 ATO
    Rosiaux, Yvonne
    Girard, Jean-Michel
    Desvignes, Florence
    Miolane, Cedric
    Marchaud, Delphine
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2015, 41 (10) : 1738 - 1744
  • [10] In vitro controlled release of colon targeted mesalamine from compritol ATO 888 based matrix tablets using factorial design
    Patel, J. K.
    Patel, N. V.
    Shah, S. H.
    RESEARCH IN PHARMACEUTICAL SCIENCES, 2009, 4 (02) : 63 - 75